ClinicalTrials.gg
Drug

Nalbuphine clinical trials

Also written Nubain.

studies test it
85
open now
21
in phase 3
15
first study started
2000

How each study uses Nalbuphine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Nalbuphine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 May 1979 · NUBAIN · NDA 018024 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nalbuphine
54
NAL ER
11
Nalufin
5
Nalbuphine Injection
3
Nalbuphine Hydrochloride Injection
3

Brand

Nubain
5

In one entry with another drug

Given together, or one or the other

Intrathecal nalbuphine and spinal anesthesia
2
Nalbuphine and Flurbiprofen Axetil
2
nalbuphine plus naloxone
2

Studies by the year they started

85 studies that test it; most in 2025 (12)

Studies that test Nalbuphine, by start year
YearStudies
20001
20041
20051
20082
20102
20131
20142
20155
20164
20172
201811
20197
20201
20215
20223
20237
20248
202512
202610

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
19
Phase 3
15
Phase 4
21
No phase
27

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 65

Trevi Therapeutics (17) · Assiut University (15) · Ain Shams University (5) · Sun Yat-sen University (2) · Cairo University (2) · University of California, San Francisco (2) · Liaquat National Hospital & Medical College (1) · CMH Lahore Medical College and Institute of Dentistry (1)

Often tested with

Tested in the same studies.

Dexmedetomidine (11) · Morphine (6) · Fentanyl (6) · Bupivacaine (4) · Spinal Block (2) · Flurbiprofen axetil (2) · Naloxone (2) · Levobupivacaine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 2 in phase 3

Studies that test Nalbuphine, phase 3 first.

Studies

Open first, then newest update. How each study uses Nalbuphine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 85

See all 85 studies that test Nalbuphine →

Given beside what is tested · 6 — Nalbuphine is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Nalbuphine

Codes

What other systems call Nalbuphine · ClinicalTrials.gg INT007865

  • MeSH (NLM) D009266NalbuphineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L2T84IQI2KNALBUPHINEConfirmed FDA, NLM, Wikidata
  • RxNorm 7238Confirmed FDA, Wikidata
  • Wikidata Q277979nalbuphineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61854NalbuphineOne source FDA
  • DrugBank DB00844One source Wikidata

Also registered as nalbuphine hydrochloride (UNII ZU4275277R · RxNorm 154985).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.